All Mylan Pharmaceuticals Inc Sponsors for H1B Applications - 2014

Explore H1B salary data for top companies like Mylan-pharmaceuticals-inc across different cities for various job titles and discover the average salaries.

Company name
Job Title
City Name
Average Salary
Mylan Pharmaceuticals Inc Scientist Morgantown $ 67,353 / Year
Mylan Pharmaceuticals Inc Senior Formulation Scientist Morgantown $ 87,000 / Year
Mylan Pharmaceuticals Inc Director Complex Product Analytics Morgantown $ 145,000 / Year
Mylan Pharmaceuticals Inc Formulator Morgantown $ 51,000 / Year
Mylan Pharmaceuticals Inc Formulation Scientist Morgantown $ 80,184 / Year
Mylan Pharmaceuticals Inc Scientist Chemistry Morgantown $ 70,000 / Year
Mylan Pharmaceuticals Inc Industrial Engineer Morgantown $ 70,000 / Year
Mylan Pharmaceuticals Inc Scientist Morgantown $ 70,000 / Year
Mylan Pharmaceuticals Inc Senior Scientistengineer Morgantown $ 86,730 / Year
Mylan Pharmaceuticals Inc Scientistengineer Morgantown $ 77,438 / Year
Mylan Pharmaceuticals Inc Technical Area Lead Morgantown $ 67,000 / Year
Mylan Pharmaceuticals Inc Scientistengineer Morgantown $ 75,000 / Year
Mylan Pharmaceuticals Inc Scientist Quality Technical Services Morgantown $ 75,000 / Year
Mylan Pharmaceuticals Inc Technical Area Lead Morgantown $ 65,000 / Year
Mylan Pharmaceuticals Inc Senior Manager Bioequivalence Morgantown $ 108,413 / Year
Mylan Pharmaceuticals Inc Senior Manager Investigations Morgantown $ 100,700 / Year
Mylan Pharmaceuticals Inc Scientist Morgantown $ 70,000 / Year
Mylan Pharmaceuticals Inc Senior Director Rd Api Sourcing Morgantown $ 150,000 / Year

Last 5 Years H-1B Salary Data

h1bInfo.org is an independent website that displays public disclosure data in a user-friendly format. We have analyzed 10 years of H1B data from USCIS and the US Department of Labor, covering more than 6 million records from FY 2014 to FY 2023. However, for the latest and most accurate data, it's best to check the official sources directly. All content on H1BInfo is copyrighted and all rights are reserved from 2022 to 2023.